REIT - Residential
Compare Stocks
5 / 10Stock Comparison
NXRT vs IRT vs NVCR vs MAA vs CPT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
Medical - Instruments & Supplies
REIT - Residential
REIT - Residential
NXRT vs IRT vs NVCR vs MAA vs CPT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Residential | REIT - Residential | Medical - Instruments & Supplies | REIT - Residential | REIT - Residential |
| Market Cap | $748M | $3.89B | $1.81B | $15.14B | $10.97B |
| Revenue (TTM) | $252M | $662M | $674M | $2.21B | $1.18B |
| Net Income (TTM) | $-32M | $48M | $-173M | $403M | $388M |
| Gross Margin | 91.1% | 20.2% | 75.2% | 23.9% | 61.3% |
| Operating Margin | 11.5% | 17.5% | -27.2% | 27.4% | 18.1% |
| Forward P/E | — | 100.7x | — | 39.0x | 68.4x |
| Total Debt | $1.56B | $2.28B | $290M | $5.41B | $3.90B |
| Cash & Equiv. | $14M | $48M | $103M | $60M | $25M |
NXRT vs IRT vs NVCR vs MAA vs CPT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NexPoint Residentia… (NXRT) | 100 | 92.2 | -7.8% |
| Independence Realty… (IRT) | 100 | 166.8 | +66.8% |
| NovoCure Limited (NVCR) | 100 | 23.6 | -76.4% |
| Mid-America Apartme… (MAA) | 100 | 111.9 | +11.9% |
| Camden Property Tru… (CPT) | 100 | 114.4 | +14.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NXRT vs IRT vs NVCR vs MAA vs CPT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NXRT ranks third and is worth considering specifically for dividends.
- 7.2% yield, 12-year raise streak, vs MAA's 4.7%, (1 stock pays no dividend)
IRT is the clearest fit if your priority is long-term compounding.
- 202.0% 10Y total return vs NXRT's 216.0%
NVCR is the clearest fit if your priority is growth exposure.
- Rev growth 8.3%, EPS growth 21.8%, 3Y rev CAGR 6.8%
- 8.3% revenue growth vs NXRT's -3.2%
MAA is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 14 yrs, beta 0.34, yield 4.7%
- Lower volatility, beta 0.34, Low D/E 92.6%, current ratio 0.16x
- Beta 0.34, yield 4.7%, current ratio 0.16x
- Better valuation composite
CPT carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 2.93 vs MAA's 3.38
- 32.8% margin vs NVCR's -25.7%
- -8.6% vs MAA's -17.6%
- 4.3% ROA vs NVCR's -16.5%, ROIC 2.6% vs -16.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.3% revenue growth vs NXRT's -3.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 32.8% margin vs NVCR's -25.7% | |
| Stability / Safety | Beta 0.34 vs NVCR's 2.20 | |
| Dividends | 7.2% yield, 12-year raise streak, vs MAA's 4.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | -8.6% vs MAA's -17.6% | |
| Efficiency (ROA) | 4.3% ROA vs NVCR's -16.5%, ROIC 2.6% vs -16.4% |
NXRT vs IRT vs NVCR vs MAA vs CPT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
NXRT vs IRT vs NVCR vs MAA vs CPT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CPT leads in 2 of 6 categories
IRT leads 1 • NXRT leads 0 • NVCR leads 0 • MAA leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CPT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MAA is the larger business by revenue, generating $2.2B annually — 8.8x NXRT's $252M. CPT is the more profitable business, keeping 32.8% of every revenue dollar as net income compared to NVCR's -25.7%. On growth, NVCR holds the edge at +12.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $252M | $662M | $674M | $2.2B | $1.2B |
| EBITDAEarnings before interest/tax | $125M | $365M | -$165M | $1.2B | $867M |
| Net IncomeAfter-tax profit | -$32M | $48M | -$173M | $403M | $388M |
| Free Cash FlowCash after capex | $79M | $139M | -$48M | $596M | $714M |
| Gross MarginGross profit ÷ Revenue | +91.1% | +20.2% | +75.2% | +23.9% | +61.3% |
| Operating MarginEBIT ÷ Revenue | +11.5% | +17.5% | -27.2% | +27.4% | +18.1% |
| Net MarginNet income ÷ Revenue | -12.7% | +7.3% | -25.7% | +18.2% | +32.8% |
| FCF MarginFCF ÷ Revenue | +31.2% | +21.1% | -7.1% | +26.9% | +60.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.5% | +2.5% | +12.3% | +0.8% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | -101.4% | -100.0% | -31.2% | +11.1% |
Valuation Metrics
Evenly matched — NXRT and CPT each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 29.6x trailing earnings, CPT trades at a 57% valuation discount to IRT's 68.8x P/E. Adjusting for growth (PEG ratio), CPT offers better value at 1.27x vs MAA's 2.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $748M | $3.9B | $1.8B | $15.1B | $11.0B |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $6.1B | $2.0B | $20.5B | $14.8B |
| Trailing P/EPrice ÷ TTM EPS | -23.40x | 68.75x | -13.02x | 34.43x | 29.59x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 100.67x | — | 38.97x | 68.38x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 2.99x | 1.27x |
| EV / EBITDAEnterprise value multiple | 18.53x | 16.80x | — | 16.50x | 16.50x |
| Price / SalesMarket cap ÷ Revenue | 2.98x | 5.91x | 2.76x | 6.86x | 6.97x |
| Price / BookPrice ÷ Book value/share | 2.49x | 1.08x | 5.20x | 2.61x | 2.56x |
| Price / FCFMarket cap ÷ FCF | 8.95x | 26.54x | — | 21.09x | 28.40x |
Profitability & Efficiency
CPT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CPT delivers a 8.7% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-51 for NVCR. IRT carries lower financial leverage with a 0.64x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), CPT scores 7/9 vs MAA's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.1% | +1.3% | -50.8% | +6.8% | +8.7% |
| ROA (TTM)Return on assets | -1.7% | +0.8% | -16.5% | +3.4% | +4.3% |
| ROICReturn on invested capital | +1.1% | +1.6% | -16.4% | +4.2% | +2.6% |
| ROCEReturn on capital employed | +1.5% | +2.4% | -28.9% | +5.6% | +3.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 4 | 7 |
| Debt / EquityFinancial leverage | 5.18x | 0.64x | 0.85x | 0.93x | 0.88x |
| Net DebtTotal debt minus cash | $1.5B | $2.2B | $187M | $5.3B | $3.9B |
| Cash & Equiv.Liquid assets | $14M | $48M | $103M | $60M | $25M |
| Total DebtShort + long-term debt | $1.6B | $2.3B | $290M | $5.4B | $3.9B |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 1.73x | -96.80x | 3.76x | 3.89x |
Total Returns (Dividends Reinvested)
IRT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IRT five years ago would be worth $12,187 today (with dividends reinvested), compared to $787 for NVCR. Over the past 12 months, CPT leads with a -8.6% total return vs MAA's -17.6%. The 3-year compound annual growth rate (CAGR) favors IRT at 2.9% vs NVCR's -38.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.5% | -5.3% | +21.0% | -4.2% | -4.0% |
| 1-Year ReturnPast 12 months | -17.3% | -11.9% | -10.6% | -17.6% | -8.6% |
| 3-Year ReturnCumulative with dividends | -17.1% | +9.0% | -76.7% | -2.9% | +6.1% |
| 5-Year ReturnCumulative with dividends | -20.9% | +21.9% | -92.1% | +3.1% | +5.4% |
| 10-Year ReturnCumulative with dividends | +216.0% | +202.0% | +40.0% | +75.2% | +71.7% |
| CAGR (3Y)Annualised 3-year return | -6.1% | +2.9% | -38.5% | -1.0% | +2.0% |
Risk & Volatility
Evenly matched — MAA and CPT each lead in 1 of 2 comparable metrics.
Risk & Volatility
MAA is the less volatile stock with a 0.34 beta — it tends to amplify market swings less than NVCR's 2.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CPT currently trades 86.3% from its 52-week high vs NXRT's 76.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.62x | 0.48x | 2.20x | 0.34x | 0.36x |
| 52-Week HighHighest price in past year | $38.64 | $19.71 | $20.06 | $167.74 | $121.33 |
| 52-Week LowLowest price in past year | $23.79 | $14.60 | $9.82 | $120.30 | $96.53 |
| % of 52W HighCurrent price vs 52-week peak | +76.3% | +83.7% | +79.2% | +77.6% | +86.3% |
| RSI (14)Momentum oscillator 0–100 | 67.6 | 64.3 | 76.7 | 56.0 | 55.9 |
| Avg Volume (50D)Average daily shares traded | 222K | 2.3M | 1.6M | 859K | 986K |
Analyst Outlook
Evenly matched — NXRT and MAA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NXRT as "Hold", IRT as "Buy", NVCR as "Buy", MAA as "Buy", CPT as "Hold". Consensus price targets imply 111.0% upside for NVCR (target: $34) vs -8.4% for NXRT (target: $27). For income investors, NXRT offers the higher dividend yield at 7.15% vs IRT's 3.99%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $27.00 | $20.08 | $33.50 | $143.71 | $112.48 |
| # AnalystsCovering analysts | 10 | 27 | 15 | 37 | 41 |
| Dividend YieldAnnual dividend ÷ price | +7.2% | +4.0% | — | +4.7% | +4.1% |
| Dividend StreakConsecutive years of raises | 12 | 4 | — | 14 | 4 |
| Dividend / ShareAnnual DPS | $2.11 | $0.66 | — | $6.05 | $4.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | +0.8% | 0.0% | +0.2% | +2.5% |
CPT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IRT leads in 1 (Total Returns). 3 tied.
NXRT vs IRT vs NVCR vs MAA vs CPT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NXRT or IRT or NVCR or MAA or CPT a better buy right now?
For growth investors, NovoCure Limited (NVCR) is the stronger pick with 8.
3% revenue growth year-over-year, versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). Camden Property Trust (CPT) offers the better valuation at 29. 6x trailing P/E (68. 4x forward), making it the more compelling value choice. Analysts rate Independence Realty Trust, Inc. (IRT) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NXRT or IRT or NVCR or MAA or CPT?
On trailing P/E, Camden Property Trust (CPT) is the cheapest at 29.
6x versus Independence Realty Trust, Inc. at 68. 8x. On forward P/E, Mid-America Apartment Communities, Inc. is actually cheaper at 39. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Camden Property Trust wins at 2. 93x versus Mid-America Apartment Communities, Inc. 's 3. 38x.
03Which is the better long-term investment — NXRT or IRT or NVCR or MAA or CPT?
Over the past 5 years, Independence Realty Trust, Inc.
(IRT) delivered a total return of +21. 9%, compared to -92. 1% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: NXRT returned +216. 0% versus NVCR's +40. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NXRT or IRT or NVCR or MAA or CPT?
By beta (market sensitivity over 5 years), Mid-America Apartment Communities, Inc.
(MAA) is the lower-risk stock at 0. 34β versus NovoCure Limited's 2. 20β — meaning NVCR is approximately 558% more volatile than MAA relative to the S&P 500. On balance sheet safety, Independence Realty Trust, Inc. (IRT) carries a lower debt/equity ratio of 64% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NXRT or IRT or NVCR or MAA or CPT?
By revenue growth (latest reported year), NovoCure Limited (NVCR) is pulling ahead at 8.
3% versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). On earnings-per-share growth, the picture is similar: Camden Property Trust grew EPS 136. 0% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, NVCR leads at 6. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NXRT or IRT or NVCR or MAA or CPT?
Camden Property Trust (CPT) is the more profitable company, earning 24.
4% net margin versus -20. 8% for NovoCure Limited — meaning it keeps 24. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MAA leads at 28. 0% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NXRT or IRT or NVCR or MAA or CPT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Camden Property Trust (CPT) is the more undervalued stock at a PEG of 2. 93x versus Mid-America Apartment Communities, Inc. 's 3. 38x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Mid-America Apartment Communities, Inc. (MAA) trades at 39. 0x forward P/E versus 100. 7x for Independence Realty Trust, Inc. — 61. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVCR: 111. 0% to $33. 50.
08Which pays a better dividend — NXRT or IRT or NVCR or MAA or CPT?
In this comparison, NXRT (7.
2% yield), MAA (4. 7% yield), CPT (4. 1% yield), IRT (4. 0% yield) pay a dividend. NVCR does not pay a meaningful dividend and should not be held primarily for income.
09Is NXRT or IRT or NVCR or MAA or CPT better for a retirement portfolio?
For long-horizon retirement investors, Mid-America Apartment Communities, Inc.
(MAA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 34), 4. 7% yield). NovoCure Limited (NVCR) carries a higher beta of 2. 20 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MAA: +75. 2%, NVCR: +40. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NXRT and IRT and NVCR and MAA and CPT?
These companies operate in different sectors (NXRT (Real Estate) and IRT (Real Estate) and NVCR (Healthcare) and MAA (Real Estate) and CPT (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NXRT is a small-cap income-oriented stock; IRT is a small-cap income-oriented stock; NVCR is a small-cap quality compounder stock; MAA is a mid-cap income-oriented stock; CPT is a mid-cap income-oriented stock. NXRT, IRT, MAA, CPT pay a dividend while NVCR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.